Gene · 566
Papers1,835
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,835
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study. | J Transl Autoimmun | 2023 | 36589266 | PubTator, text mining | PubMed |
| Impact of peri-implantitis on the proteome biology of crevicular fluid: A pilot study. | J Periodontol | 2023 | 36585920 | PubTator, text mining | PubMed |
| Efficient combinatorial targeting of RNA transcripts in single cells with Cas13 RNA Perturb-seq. | Nat Methods | 2023 | 36550277 | PubTator, text mining | PubMed |
| Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network. | Cancer Sci | 2023 | 36541519 | PubTator, text mining | PubMed |
| Heparin-binding protein as a biomarker of severe sepsis in the pediatric intensive care unit: A multicenter, prospective study. | Clin Chim Acta | 2023 | 36460135 | PubTator, text mining | PubMed |
| The Olfactomedin-4-Defined Human Neutrophil Subsets Differ in Proteomic Profile in Healthy Individuals and Patients with Septic Shock. | J Innate Immun | 2023 | 36450268 | PubTator, text mining | PubMed |
| Human neutrophils ≠ murine neutrophils: Does it matter? | Immunol Rev | 2023 | 36380497 | PubTator, text mining | PubMed |
| Protein disulfide isomerase A3 activity promotes extracellular accumulation of proteins relevant to basal breast cancer outcomes in human MDA-MB-A231 breast cancer cells. | Am J Physiol Cell Physiol | 2023 | 36374169 | PubTator, text mining | PubMed |
| A case with cardiac, skeletal, speech, and motor traits narrows the subtelomeric 19p13.3 microdeletion region to 46 kb. | Am J Med Genet A | 2023 | 36271830 | PubTator, text mining | PubMed |
| Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes. | Blood | 2023 | 36223592 | PubTator, text mining | PubMed |
| Anomalies in Human Sex Determination: Usefulness of a Combined Cytogenetic Approach to Characterize an Additional Case with Xp Functional Disomy Associated with 46,XY Gonadal Dysgenesis | J Clin Res Pediatr Endocrinol | 2023 | 35984215 | PubTator, text mining | PubMed |
| Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome. | J Cardiovasc Transl Res | 2023 | 35727504 | PubTator, text mining | PubMed |
| Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations. | Blood Adv | 2023 | 35381066 | PubTator, text mining | PubMed |
| COVID-19 vaccine (Ad26.COV2.S), an unlikely culprit of portal vein thrombosis in a middle-aged man. | Thromb Update | 2022 | 38620988 | PubTator, text mining | PubMed |
| Quantitative tissue proteome profile reveals neutrophil degranulation and remodeling of extracellular matrix proteins in early stage gallbladder cancer. | Front Oncol | 2022 | 36686780 | PubTator, text mining | PubMed |
| The Endothelial Glycocalyx and Neonatal Sepsis. | Int J Mol Sci | 2022 | 36613805 | PubTator, text mining | PubMed |
| Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2022 | 36597436 | PubTator, text mining | PubMed |
| The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates. | BMC Mol Cell Biol | 2022 | 36564747 | PubTator, text mining | PubMed |
| HIGH HEPARANASE LEVEL IN SURVIVORS OF COVID-19 - INDICATOR OF VASCULAR AND PULMONARY RECOVERY? | Shock | 2022 | 36548643 | PubTator, text mining | PubMed |
| Development of Growth Factor Releasing Hyaluronic Acid-Based Hydrogel for Pulp Regeneration: A Preliminary Study. | Gels | 2022 | 36547349 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/566/papers?page=19